Research Associate

Research Associate

Cellectis Inc.

New York, France

<!—
/* Font Definitions /
@font-face
{font-family:Arial;
panose-1:2 11 6 4 2 2 2 2 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
{font-family:“Courier New”;
panose-1:2 7 3 9 2 2 5 2 4 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:fixed;
mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;
mso-font-charset:2;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
{font-family:“Cambria Math”;
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:variable;
mso-font-signature:-536870145 1107305727 0 0 415 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
{font-family:ArialMT;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-536859905 -1073711037 9 0 511 0;}
/
Style Definitions /
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:“Times New Roman”,serif;
mso-fareast-font-family:“Times New Roman”;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
mso-themecolor:hyperlink;
text-decoration:underline;
text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-noshow:yes;
mso-style-priority:99;
color:#954F72;
mso-themecolor:followedhyperlink;
text-decoration:underline;
text-underline:single;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:“Times New Roman”,serif;
mso-fareast-font-family:“Times New Roman”;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:“Times New Roman”,serif;
mso-fareast-font-family:“Times New Roman”;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:“Times New Roman”,serif;
mso-fareast-font-family:“Times New Roman”;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:“Times New Roman”,serif;
mso-fareast-font-family:“Times New Roman”;}
span.Hyperlink1
{mso-style-name:“Hyperlink\.1”;
mso-style-unhide:no;
mso-ansi-font-size:11.0pt;
mso-bidi-font-size:11.0pt;
font-family:“Arial”,sans-serif;
mso-ascii-font-family:Arial;
mso-fareast-font-family:Arial;
mso-hansi-font-family:Arial;
mso-bidi-font-family:Arial;
color:black;
mso-ansi-language:EN-US;
text-underline:black;}
span.summary
{mso-style-name:summary;
mso-style-unhide:no;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-family:“Calibri”,sans-serif;
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:“Times New Roman”;
mso-bidi-theme-font:minor-bidi;
mso-fareast-language:EN-US;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.WordSection1
{page:WordSection1;}
/
List Definitions */
@list l0
{mso-list-id:537279693;
mso-list-type:hybrid;
mso-list-template-ids:256510196 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1
{mso-list-id:1206796831;
mso-list-type:hybrid;
mso-list-template-ids:1939874826 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l2
{mso-list-id:1959601080;
mso-list-type:hybrid;
mso-list-template-ids:-2136158536 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:“Courier New”,serif;}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:?;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
—>

Cellectis is a
clinical-stage biopharmaceutical company focused on developing a new generation
of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing
on its 19 years of expertise in gene editing – built on its flagship TALEN® technology
and pioneering electroporation system PulseAgile – Cellectis uses the power of
the immune system to target and eradicate cancer cells.

Using its
life-science-focused, pioneering genome engineering technologies, Cellectis’
goal is to create innovative products in multiple fields and with various
target markets. Cellectis is listed on the Nasdaq (ticker: CLLS) and on
Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com

Talking about
gene editing? We do it. TALEN® is a registered trademark owned by Cellectis.

 

Job summary:

We are seeking a highly creative and motivated individual to join us in developing
the next generation of gene and cell therapies for rare diseases.  The successful applicant will have a strong
scientific background and proven accomplishments in molecular and cellular
biology with a passion for genome editing and gene therapy.  As part of the gene therapy group, the
candidate will contribute to our ongoing efforts to develop
differentiated therapeutic approaches using our gene editing technology. 
Candidates should be highly
self-motivated with the ability to excel in a fast-moving, goal-oriented
environment.

 

The successful
candidate will:

 

·      
Work closely with
scientists to develop next-generation gene and cell therapies using genome
editing

·      
Design and execute
functional assays of cells of the hematopoietic system including ex vivo and in
vivo analysis

·      
Multi-parameter
analyses of hematopoietic cells including flow cytometry and other molecular
and cellular assays

·      
Work with a
cross-disciplinary team to optimize hematopoietic stem cell culture and editing
approaches

 

Qualifications:

 

·      
BS/MS in biology, cellular
and molecular biology, genetics, or related discipline with 1+ years lab
experience.

·      
Strong knowledge of
cellular biology techniques (cell culture, viral transduction, transfection) as
well as cell-based assays

·      
Solid experience with
murine model handling (injections- IV, SC, IP- and organ dissection).

·      
Experience with hematopoietic
stem cell biology is a plus

  • Excellent
    troubleshooting and multi-tasking skills, attention to detail and ability
    to work independently are required

 

Location:

·      
Cellectis, Inc. is located
in the Alexandria Center for Life Science in New York City

 

How to Apply

 

Applicants
should send their CV, a description of their research experience and interest
to
CLI_RAS_2019-02@cellectis.com

 

Favorite

Apply with CV and Cover Letter

Fields with a * are mandatory
Must be a .doc, .docx, or .pdf file and no larger than 1MBMust be a .doc, .docx, or .pdf file and no larger than 1MB
Position

Research Associate